Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFR.L Regulatory News (AFR)

  • There is currently no data for AFR

Form 8 (DD) - Afren Plc

8 Jan 2015 11:05

RNS Number : 6556B
Afren PLC
08 January 2015
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Afren plc ("Afren")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Afren

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

07 January 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary Shares of 1p each

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

nil

nil

(2) Cash-settled derivatives:

Β 

nil

nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

nil

Β 

TOTAL:

nil

nil

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

Β 

Details of the Afren's directors' interests are set out below:

Directors of Afren

Number of Afren shares

Egbert Imomoh

5,404,411

Darra Comyn

823,605

John St. John

177,823

Iain Mclaren

30,000

Total

6,435,839

Β 

The directors of the Company have the following beneficial interests in shares in the Company pursuant to the Company 's share option scheme:

Β 

Egbert Imomoh

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

200,000

28/06/2005

20.00p

01/03/2006-01/03/2007

27/06/2015

500,000

28/06/2005

50.00p

28/06/2005-01/03/2006

27/06/2015

500,000

28/06/2005

100.00p

28/06/2005-01/03/2007

27/06/2015

600,000

30/05/2006

63.00p

30/05/2007-30/05/2009

29/05/2016

250,000

28/03/2007

80.00p

28/03/2007-28/03/2010

27/03/2017

250,000

28/03/2007

120.00p

28/03/2007-28/03/2010

27/03/2017

250,000

28/03/2007

180.00p

28/03/2007-28/03/2010

27/03/2017

750,000

23/01/2009

23.25p

23/01/2010-23/01/2012

23/01/2019

Darra Comyn

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

650,000

30/12/2009

84.75p

30/12/2010-30/12/2012

30/12/2019

1,200,000

29/03/2010

103.00p

29/03/2011-29/03/2013

28/03/2020

John St. John

No. of Shares

Grant Date

Exercise Price

Exercisable from

Exercisable to

400,000

21/06/2007

70.00p

21/06/2007-21/06/2009

20/06/2017

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

none

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

none

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

08 January 2015

Contact name:

Anne Vallely

Telephone number:

+44 20 7864 3700

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DCCPKFDKDBKDNDK
Date   Source Headline
31st Jul 201510:39 amRNSCorporate update
27th Jul 20157:00 amRNSUpdate on General Meeting
21st Jul 20154:31 pmRNSUpdate on Upcoming General Meeting
15th Jul 20157:33 amRNSOperational and financial update
15th Jul 20157:30 amRNSSuspension - Afren PLC
8th Jul 20157:00 amRNSPublication of Supplementary Prospectus
1st Jul 20154:54 pmRNSDirector Declaration
25th Jun 20153:31 pmRNSResult of AGM
25th Jun 201511:00 amRNSAGM Statement
25th Jun 20157:00 amRNSBoard changes
22nd Jun 20157:00 amRNSLaunch of shareholder information microsite
19th Jun 20156:26 pmRNSProposed Debt Restructuring and Refinancing
12th Jun 20154:06 pmRNSExecutive Director Resignation / COO Appointment
10th Jun 20157:00 amRNSInterest payment due on 2020 Notes
29th May 20157:00 amRNSInterim Management Statement
29th May 20157:00 amRNSFinal Amount of the New Senior Notes
28th May 201510:58 amRNSNotification of Major Interest in Shares
18th May 20157:00 amRNSResignation of Non-Executive Directors
11th May 20157:00 amRNSInterest payment due on 2019 Notes
30th Apr 20154:37 pmRNSAnnual Financial Report
30th Apr 20154:34 pmRNSCompletion of interim funding
30th Apr 20154:31 pmRNS2014 Full Year Results
9th Apr 20157:00 amRNSInterest payment due on 2019 Notes
8th Apr 201510:34 amRNSResponse to AMNI's allegations regarding Okoro
7th Apr 201511:40 amRNSResponse to reports regarding CEO
1st Apr 20152:08 pmRNSUpdate on interim funding
30th Mar 20154:35 pmRNSPrice Monitoring Extension
23rd Mar 20157:00 amRNSUpdate on discussions with bondholders
20th Mar 20154:40 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Mar 20154:40 pmRNSSecond Price Monitoring Extn
16th Mar 20154:35 pmRNSPrice Monitoring Extension
13th Mar 20157:00 amRNSTrading statement and operations update
4th Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
2nd Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
17th Feb 20152:27 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
17th Feb 20152:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 20155:44 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 201511:30 amRNSForm 8.5 (EPT/RI)
16th Feb 201511:07 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:06 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:01 amPRNForm 8.3 - Afren Plc
16th Feb 201510:46 amRNSForm 8.5 (EPT/RI)
13th Feb 20154:35 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:01 pmRNSOffer Talks Terminated
13th Feb 20152:49 pmBUSForm 8.3 - AFREN PLC
13th Feb 20152:17 pmRNSForm 8.3 - [Afren PLC]
13th Feb 20151:56 pmRNSOffer Talks Terminated
13th Feb 20151:43 pmRNSForm 8.3 - Afren PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.